期刊
HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 12, 期 5, 页码 1102-1116出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2015.1122146
关键词
biosafety; measles virus (MV); MV Edmonston strains; vaccination; viral vectors; virotherapy
资金
- Brussels-Capital Region (IBGE-BIM)
- Flemish Region (LNE)
- Wallonia (DGARNE)
Attenuated measles virus (MV) is one of the most effective and safe vaccines available, making it attractive candidate vector to prevent infectious diseases. Attenuated MV have acquired the ability to use the complement regulator CD46 as a major receptor to mediate virus entry and intercellular fusion. Therefore, attenuated MV strains preferentially infect and destroy a wide variety of cancer cells making them also attractive oncolytic vectors. The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据